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INTRODUCTION 
Ulcerative colitis is a recurrent chronic inflammatory 
disease of the intestines with unknown etiology and is 
associated with Crohn’s disease which is categorized in 
IBD class. This disease is caused by abnormal local 
immune system response to intestinal flora or may be to 
some self-antigens in genetically susceptible individuals. 
Ulcerative colitis is a non-granulomatous disease limited 
to the colon and with exception in severe cases is limited 
to the mucosa and submucosa.
1
 It is estimated that the 
number of people with this disease in Iran is near to 
10000 people. The incidence of the disease has increased 
in recent decades. The incidence of Crohn’s disease and 
ulcerative colitis in different geographic regions vary 
from 0.1 to 11 and 0.5 to 24.5 per 1000 person, 
respectively.
2
 The disease is more common in whites in 
the United States and there was no sexual preference. The 
incidence of Colitis in North America is 10-12 per 
100000 people, with a peak age incidence of 15-25 years 
old.
3
 The incidence of ulcerative colitis is one in a 
thousand. The overall shape of the data distribution of 
ulcerative colitis is as a bi-wavelike in which a second 
peak occurs in the sixth decade of human life and affects 
women more than men. Geographical distribution of 
colitis and colonic diseases in the world is the same with 
high incidence in United States, Canada, United 
Kingdom and Scandinavia. High incidence has been seen 
in northern Europe and America than in southern.
4
 The 
most incidence rate of inflammatory bowel disease is 
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seen in the second and third decades of life. The 
incidence of inflammatory bowel disease varies in 
different geographic areas.
5
 The highest incidence of 
Crohn’s disease and ulcerative colitis occurs in Europe, 
United Kingdom and North America.
6-7
 Inflammatory 
bowel disease with except of Israel Australia and South 
Africa is rare in other regions.
8-9
 The highest mortality 
rate in patients with IBD is during early years of disease 
and in long-term is because of colon cancer. The 
prevalence of IBD is high in urban areas than in rural 
areas and in rich socio-economic classes than poor.
10
 
Inflammatory bowel diseases are more prevalent in the 
West and in Iran because of changing foods from 
traditional form to fast foods, the incidence paradigm is 
changed. Inflammatory bowel disease was low in the past 
but now the disease is increasing. The exact cause of the 
Crohn’s disease and ulcerative colitis and their effects on 
suffered patients has not known. Some people live with 
this disease for a long time without any signs of disease 
but in others the disease constantly recurs so that, it may 
chronically occur at any age. Crohn’s disease and 
ulcerative colitis are not of common gastrointestinal 
diseases and are not associated with high mortality but, 
are considered in some countries due to its impact on 
quality of life, increased mortality, recurrence and the 
recent increase in their prevalence. Recognition of 
epidemiological features and risk factors play an 
important role in disease management. Based on a report 
from Sweden, the prevalence rate of Crohn’s disease 
during years is increased from 2.4% per 100 thousand 
children in 1990-1992 to 4.5% per 100 thousand children 
in 1996-1998. Contrary, incidence of ulcerative colitis is 
constant.
11
 In Iran, a report indicated 140 patients with 
Crohn’s disease during years 1989-1999 indicates that 
however Crohn’s disease is rare in Iran but, its incidence 
is growing up.
12
 The reasons for the increase of IBD in 
Iran can note to the changes in diet and lifestyle, increase 
in urban population, increase in sanitary level and 
vaccination as factors affecting the development of IBD. 
It seems that, modernization of lifestyle such as changes 
in diet and sanitary in developing countries like Iran has 
occurred decades later than in Western societies and has 
caused increase in inflammatory bowel disease in recent 
years. For this reason, determination the prevalence rate 
and its risk factors can reveal the severity of the problem 
and reveal the necessity of prevention, ways of 
prevention and reduction of incidence.
13-14
 
Appendectomy before age 20 and smoking increase the 
incidence of ulcerative colitis.
15-16
 Many references have 
noted ulcerative colitis as an autoimmune disease.
17
 In 
contrast of colon disease, ulcerative colitis is less 
occurred in smokers than non-smokers.
18,19
 Due to the 
lack of comprehensive studies in this filed, present study 
designed for epidemiologic evaluation of ulcerative 
colitis and its clinical signs in Ardebil city of Iran.  
METHODS 
This study was conducted as retrospective cross-sectional 
method in that 80 patients with ulcerative colitis were 
examined. This study was carried out during 2003-2011 
on patients referred to Imam Khomeini hospital of 
Ardebil. Diagnosis was based on clinical signs, fecal 
examination, colonoscopy and pathology findings and 
rejection of other similar disorders such as infectious 
colitis, drugs, ischemic colitis, diverticular colon 
diseases, colon cancer and single lesion of colon. Data 
were obtained from patients’ document archived in 
hospital. Data were recorded in the questionnaires which 
were information about patients’ demographical and 
clinical characteristics including age, marital status, 
anatomic status, drugs used, history of smoking, history 
of consumption of OCPs and history of appendectomy. In 
colonoscopy, criteria indicating colon disorders were 
graded as follow:  
Grade 1: Rectal involvement 
Grade 2: Recto-sigmoid involvement  
Grade 3: Left colon involvement 
Grade 4: Pancolitis 
Grade 5: None of the above mentioned factors  
Data were analyzed using SPSS and descriptive methods. 
Data were given as Mean ± SD. 
RESULTS 
Of 80 patients with ulcerative colitis (age range 10-85 
years old and age average 36.41 ± 18.43), 38 of them 
were male (47.5%) and 42 of them were female (52.5%). 
20 of them were single (25%) and 60 of them got married 
(75%). 53 of them were urban (66.25%) and 27 of them 
were rural (33.75%). 22 of them were uneducated 
(27.5%), 54 of them were sub-diploma (67.5%) and 4 of 
them were higher educated (5%) (Table 1). 
3 patients (3.75%) had family history of ulcerative colitis. 
5 patients (6.25%) had history of smoking, 2 patients 
(2.5%) had history of opium and 4 patients (5%) had 
history of alcohol. Of 42 women, 22 (52.38%) of them 
had history of OCP consumption. Among patients, 4 
(5%) of them had history of appendectomy. Colonoscopic 
findings showed that 1 patient (1.25%) had rectal 
involvement, 27 (33.75%) of them had recto-sigmoid 
involvement, 23 (28.75%) of them had left colon 
involvement, 4 (5%) of them had pancolitis and in 25 
(31.25%) of them determination of inflammation period 
has not been made because of incomplete colonoscopy. 
31 patients (38.75%) were positive in term of biopsy 
(Table 2). 39.5% of men and 26.2% of women were in 
age range 20-30 years old (Figure 1). The maximum 
incidence was in age range 20-30 years old with 26 
patients (32.5%) (Table 3). Based on results of present 
study, incidence and prevalence rate of ulcerative colitis 
in Ardebil city calculated 2.72 and 19.1 per 100 thousand 
people (Table 4). 
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Table 1: Demographic properties of patients with UC.  
Variable  Frequency  
Sex  
Man 38 (47.5%) 
Woman 42 (52.5%) 
Age  
Age range 85-10 
Mean  36.42 
Mode 26 
Median  30 
Variance  339.79 
Standard deviation  18.43 
Marital status  
Single 20 (25%) 
Married  60 (75%) 
Location  
Urban 53 (66.25%) 
Rural  27 (33.75%) 
Education  
Uneducated 22 (27.5%) 
Sub-diploma 54 (67.5%) 
High educated  4 (5%) 
Table 2: Clinical findings and risk factors.   
History  
Frequency 
(percent) 
Positive  3 (3.75%) 
Smoking 5 (6.25%) 
Opium  2 (2.5%) 
Alcohol 4 (5%) 
OCP 22 (52.38%) 
Appendectomy  4 (5%) 
Colonoscopic 
findings 
Rectal 1 (1.25%) 
Recto-sigmoid 27 (33.75%) 
Left colon 23 (28.75%) 
Pancolitis 4 (5%) 
Other  25 (31.25%) 
Biopsy compatible with UC 31 (38.75%) 
 
 
Figure 1: Age distribution of patients in term of sex.  
Table 3: Patient’s distribution based on age and sex.  
Sex  
Age 
range 
Man Woman  
No. % No. % 
10-20 10 26.3 5 11.9 
20-30 15 39.5 11 26.2 
30-40 5 13.2 9 21.4 
40-50 2 5.3 5 11.9 
50-60 0 0 5 11.9 
60-70 3 7.9 6 14.3 
70-80 2 5.3 1 2.4 
>80 1 2.6 0 0 
Total 38 47.5 42 52.5 
Table 4: calculation of Ardebil population, prevalence 
and incidence rate. 
Year 
Calculated 
population 
Man Woman Total Incidence  
2003 398213 7 4 11 2.78 
2005 405441 3 10 13 3.2 
2007 412669 5 8 13 3.15 
2008 419897 5 9 14 3.3 
20009 427125 8 5 13 3.04 
2010 434353 9 2 11 2.53 
2011 441581 1 4 5 1.1 
Years Average 
Total 
men 
Total 
women 
Incidence 
rate  
Prevalence 
rate 
8 419897 38 42 2.72 19.1 
DISCUSSION 
One of the reasons for referring patients to 
gastroenterology specialists is inflammatory bowel 
disease in which, ulcerative colitis, is the most common 
among them. The causes of the disease are unknown, but 
make long-term complications and have variable 
gastrointestinal side effects. Due to the lack of 
recordkeeping centers in IRAN, studies have not been 
performed about UC. Based on the material contained in 
the reference books and medical texts it seems that the 
disease in women is partially more than men, and in most 
cases is almost identical.
1
 In present study also women 
were (52.5%) and men were (47.5%) with the sexual ratio 
of 0.8:1. Studies carried out in Tehran and Kerman also 
showed 55 and 55.3% of women respectively.
1,9
 The age 
average I present study was 36.4 years old which was a 
little more than other studies with 33.3 years old.
1,18,19
 
Studies carried out in European societies in two age range 
but our study was carried out in age range 20-30 years 
old and results showed compatibility with previous 
studies.
18-20
 which indicates disease peak in this age 
group. Based on some studies, smoking has preventive 
effects on incidence of UC but its reason is not clear.
10
 
Based on results of present study, only in 6.25% of 
patients, the history of smoking was seen, which is in line 
with other studies.
13,18
 and observed that it has protective 
effect in UC. According to the previous studies, 
consumption of OCP has reveres effect in UC. In present 
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study, use of OCPs (52.4%) was more than other studies 
with 6 and 19.1% and because of absence of control 
group, we couldn’t conclude about results statistically 
significance.
13,18
 Recent studies have described reveres 
significant difference between appendectomy and UC.
19
 
In previous studies, the history of appendectomy was 1.8 
and 5.9% respectively which was incompatible with our 
results of 5%.
18,21
 The protective role of appendectomy 
was not the aims of present study. Various studies in 
Asian and western countries have reported different 
extent of the disease.
22
 In a research in Korea, result 
showed 34% proctic patients, 35.1% left colon colitis and 
30.9% diffused colitis.
23
 In Arak, rectal 26.8%, recto-
sigmoid 29.9% and pancolitis observed 11.3%.
11
 In 
Kerman, rectal 8.3%, recto-sigmoid (23.5%) and 
pancolitis observed 18.8%.
18
 In present study, rectal 
1.25%, recto-sigmoid 33.75% and pancolitis observed 
5% which was relative compatible with other studies. In 
our research, Recto-sigmoid and left colon was the most 
common site of involvement (33.75 and 28.75% 
respectively) and pancolitis observed 5% of patients. 
Ebrahimi et al., 2001 showed rectal and recto sigmoid as 
high prevalence with 70 and 14% respectively then 
showed pancolitis 8% prevalence.
18
 In other studies, it 
has been shown that 40-50% of patients have rectal and 
recto-sigmoid involvement and 30-40% have upper tract 
involvement and 20% is related to large intestine.
18,19
 It 
seems that, the results obtained from present study is 
according to the world statistics, however, severe 
pancolitis in present study was lesser than other studies. 
The incidence and prevalence of UC in present study was 
2.72% and 19.1 per 100000 people. The average of 
prevalence in men and women was 18.1 and 20 per 
100000 people respectively. The prevalence and 
incidence rates in present study was not according to 
other studies in Sweden (incidence 2.1%), America 
(prevalence 35-100%), Colombia (prevalence 29%), 
Amman (prevalence 10.4%), Barbados (incidence 1.85), 
California (incidence 3.2) per 100000 people.
11,22,24-27
 
Study carried out in Colombia showed prevalence 30.4 
for women and 12 for men which was in contrast of our 
study.
25 
can state that, IBD is a most common in West of 
the world and its incidence has increased since 1950.
28
 
Jess et al., 2007 worked on manifestations, clinical course 
and prognosis of IBD in 3 different groups and concluded 
that the patients’ suffered from IBD and Crohn’s disease 
is increased since 1962-2005 and the time spent from 
incidence till diagnosis has been decreased. The 
prevalence of proctic was more in patients with UC as 
well as the operation was decreased and mortality was 
increased.
29
 Increase in prevalence and incidence rates of 
UC is increased in Asian countries and according to the 
studies from 1990 to 2006 it has been shown that of 73 
patients with age average of 40.6 and average of disease 
course 72 months, 38.4% proctic UC, 26% left colon UC 
and 35.6% extended UC was observed.
20
 Chronic UC has 
increasingly violent course in developing countries, in 
Amman, 372 UC patients has been recorded from 1994 to 
2007. Dysentery and abdominal pain were the most 
prevalent signs (84%). Age average of patients was 31.8 
and in 2.3% of patients, the diagnosis was made 1 year 
post incidence.
22
 The age average in present study was 
36.4 years old which is consistent with that study. Karoui 
et al., 2007 worked on 70 patients with UC from 1984 to 
2004 and showed that the primary site of involvement 
was rectum and recto-sigmoid with 25 and 45 cases, 
respectively in which by tracking of patients for 49.4 
month, the 10% of disease was extent to proximal areas 
in 7 patients. Most cases of recurrence in patients were 
with colon condition.
30
 The findings show that smoking 
reduces disease symptoms and has a protective role 
against developing ulcerative colitis which is confirmed 
in our study. Age, sex, primary site of involvement, 
treatment and diagnosis of distal UC were not associated 
with increased risk of colon. In present study, recto-
sigmoid was more incidence rate which is in contrast of 
Jess et al., 2007.
29
 Lakatos 2006 indicated that smoking is 
an important environmental factor in patients with IBD 
and has different effects on patients with UC and Crohn’s 
disease.
28
 By analyzing of previous results it shown that 
smoking has positive protective effect on UC and may 
improve healing after incidence and reduces the need to 
colonoscopy whereas, smoking increased the rate of 
Crohn’s disease and severe it and increased need to 
inmunosuppressor steroid. Stop smoking aggravates 
ulcerative colitis and is improved Crohn’s disease. The 
incidence risk of IBD is at any age but UC is seen mostly 
in adults. In present study, patients’ age range was 36.42 
years old which is compatible with other studies.24-26 
Aghazadeh et al., 2005 showed that age range among 457 
patients with UC is 31.9 years old with men to women 
ratio 0.8:1, 84.5% non-smokers and 51.9% of UC were 
proctosigmoid.
2
 UC is more common in urban than rural 
areas because of easier access to health care, jobs, the 
environment and nutrition which is consistent with our 
results (66.25% VS 33.75%). UC was more common in 
patients with low educations (67.5%) which indicates 
close relationship between public awareness and UC (P = 
0.001). 
CONCLUSION 
Based on present study, UC in Iran is close in results of 
previous studies carried out worldwide; however, there 
are some differences in some factors and needs to 
accurate treatment and medicine administration. We 
conclude that, colon involvement in UC is varying in 
different geographic regions thus we recommend that it 
still needs to other studies with different and accurate 
methods with designated criteria in research centers to 
achieve accurate statistic about colon involvement in UC 
for better detection and treatment.  
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